FindTrial
Sign In

Validation process of liquid biopsy for solid tumors

Technical Validation of Liquid biopsy for solid tumors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/03/050258
Enrollment
2000
Registered
2023-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D499- Neoplasm of unspecified behavior of unspecified site

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Cancer Research and Statistic Foundation CRSF
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All cancer patients registered in Homi Bhabha Cancer Hospital & Research Center, Muzaffarpur

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Establishment of proper storage and preservation â?? BiorepositoryTimepoint: 5 years—

Secondary

MeasureTime frame
Analysis of sequenced result to come up with novel finding with translational impact.Timepoint: 5 year;Extraction of DNA/RNA from rare tumor samples, samples with specific requirements like metastatic or on progression cases.Timepoint: Every month;Monthly evaluation of total number of samples (in pair tissue and blood) collected/extracted.Timepoint: Every month—

Countries

India

Contacts

Public ContactDr Ravikant Singh

Homi Bhabha Cancer Hospital and Research Center

ravikant.tmh@gmail.com9110901500

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026